Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 55Recruiting 33Unknown 14Active not recruiting 12Terminated 5Not yet recruiting 5Withdrawn 4Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Gastrointestinal 10Tumor-Agnostic 8Thoracic 8Genitourinary 7Breast 5Dermatologic 4CNS 4Sarcoma 3Plasma cell 3Gynecologic 3Lymphoid 2Other 1Head & Neck 1Endocrine 1

Conditions

Breast Neoplasms 5Recurrence 1Neoplasms 1Neoplasm Metastasis 1

Interventions

Trastuzumab 87Cyclophosphamide 67Capecitabine 67Paclitaxel 64Docetaxel 58Fulvestrant 52Letrozole 50Carboplatin 42pembrolizumab 41Lapatinib 38Doxorubicin 36Anastrozole 32Vinorelbine 31Bevacizumab 31exemestane 28Tamoxifen 25Gemcitabine 25Albumin-Bound Paclitaxel 25Radiotherapy 21Taxes 19atezolizumab 18pertuzumab 17Everolimus 17130-nm albumin-bound paclitaxel 17Epirubicin 16palbociclib 15Magnetic Resonance Spectroscopy 15eribulin 14Ado-Trastuzumab Emtansine 14Goserelin 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Terminated × Blood Specimen Collection × Breast × Clear all
NCT04995575 2024-02-22

MINDACTRelapse

European Organisation for Research and Treatment of Cancer - EORTC

Terminated
31 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Recurrence

NCT02696759 2022-03-16

Gut Microbiome & Gastrointestinal Toxicities as Determinants of Response to Neoadjuvant Chemo for Advanced Breast Cancer

University of Arkansas

Phase NA Terminated
15 enrolled 6 charts
Breast

Breast Neoplasms, Neoplasms

NCT02907918 2021-09-29

PALTAN

Washington University School of Medicine

Phase 2 Terminated
26 enrolled 8 charts
Breast

Breast Neoplasms

NCT00651976 2018-10-15

Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery

Vanderbilt-Ingram Cancer Center

Phase EARLY_PHASE1 Terminated
213 enrolled
Breast

Breast Neoplasms

NCT00537173 2017-01-25

Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer

Hoosier Cancer Research Network

Terminated
11 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡